Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer discussed, along with the tech battleground. Answering a caller’s query about the stock during the lightning round, Cramer ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Wondering if Recursion Pharmaceuticals at around $4.83 is a beaten down bargain or a value trap? This breakdown walks through what the current market price is really implying. The stock has bounced ...

Swift's docuseries is now streaming on Disney+. Taylor Swift's docuseries "The End of an Era" is here. All six episodes of the singer's highly anticipated docuseries on her record-breaking Eras Tour ...

These days, iPhones can do a lot. And we mean a lot. From photography and navigation to gaming and AI, it’s enough to make you forget they can also, you know, make phone calls and send text messages.

Kaitlin Sullivan is a health and science journalist based in Colorado. She's been part of multiple award-winning investigations into health topics including the international medical device industry ...

Bret Bielema has said he expects a handful of players from this class to make an impact right away, and safety Jacob Eberhart, cornerback Almirian Thomas and linebacker Cam Thomas are among those who ...